As previously reported, Argus upgraded Herbalife (HLF) to Buy from Hold. The firm cites the company’s Q3 earnings beat reported earlier this month while also boosting its FY25 EPS view by 3c to $2.15 and its FY26 view by 4c to $2.64, the analyst tells investors in a research note. Argus adds however that while Herbalife’s reported revenue rose 270bps y/y, it was hurt by foreign currency headwinds.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF: